For Patients With HCV Genotype-4 Infection, Retreatment For NS5A Treatment Nonresponse May Be Effective, Study Indicates
April 23, 2020
Infectious Disease Advisor (4/22, van Paridon) reports, “For patients with hepatitis C virus (HCV) genotype-4 infection, retreatment for nonstructural protein 5A (NS5A) treatment nonresponse was effective and well-tolerated in both noncirrhotic and compen...